Despite ringing endorsements for the Covid drug, available data about its effectiveness are lacking.
The Biden administration and other governments around the world have bet big on Pfizer’s Covid-19 pill, Paxlovid (Nirmatrelvir/Ritonavir). The administration touts widespread availability, and White House Covid czar Ashish Jha says that it’s “good news” that people are using it more.
